Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 26 Aug 2022 13:17 CEST |
GENTIAN DIAGNOSTICS ASA | Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 25 Aug 2022 16:28 CEST |
GENTIAN DIAGNOSTICS ASA | Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 25 Aug 2022 08:00 CEST |
GENTIAN DIAGNOSTICS ASA | Second quarter 2022 report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 23 Aug 2022 13:05 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics signs distribution agreement for Cystatin C | 20103010 Biotechnology | Non-regulatory press releases |
| 18 Aug 2022 12:41 CEST |
GENTIAN DIAGNOSTICS ASA | Invitation to presentation of second quarter results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 May 2022 12:22 CEST |
GENTIAN DIAGNOSTICS ASA | Minutes of annual general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 May 2022 09:29 CEST |
GENTIAN DIAGNOSTICS ASA | The nomination committee's recommendation to the general meeting of Gentian Diagnostics ASA | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2022 08:58 CEST |
GENTIAN DIAGNOSTICS ASA | Annual report 2021 | 20103010 Biotechnology | Annual financial and audit Reports |
| 28 Apr 2022 08:00 CEST |
GENTIAN DIAGNOSTICS ASA | First quarter 2022 financial report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 27 Apr 2022 21:16 CEST |
GENTIAN DIAGNOSTICS ASA | NOTICE OF ANNUAL GENERAL MEETING | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Apr 2022 08:27 CEST |
GENTIAN DIAGNOSTICS ASA | Invitation to presentation of first quarter 2022 results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Apr 2022 14:10 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics signs distribution agreement with leading global diagnostics company for Cystatin C | 20103010 Biotechnology | Inside information |
| 29 Mar 2022 09:37 CEST |
GENTIAN DIAGNOSTICS ASA | Release of the Gentian SARS-CoV-2 Total Antibody Immunoassay | 20103010 Biotechnology | Non-regulatory press releases |
| 28 Feb 2022 12:19 CET |
GENTIAN DIAGNOSTICS ASA | Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 17 Feb 2022 08:00 CET |
GENTIAN DIAGNOSTICS ASA | Fourth quarter and full year 2021 report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 11 Feb 2022 10:42 CET |
GENTIAN DIAGNOSTICS ASA | Invitation to presentation of 2021 fourth quarter results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 31 Jan 2022 14:00 CET |
GENTIAN DIAGNOSTICS ASA | Global GCAL® distribution contract with Siemens Healthineers | 20103010 Biotechnology | Inside information |
| 16 Dec 2021 13:33 CET |
GENTIAN DIAGNOSTICS ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Dec 2021 08:47 CET |
GENTIAN DIAGNOSTICS ASA | Completed development of SARS Cov-2 antibody assay | 20103010 Biotechnology | Non-regulatory press releases |
| 16 Dec 2021 08:34 CET |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics presents at the DNB Nordic Healthcare Conference | 20103010 Biotechnology | Non-regulatory press releases |
| 10 Dec 2021 09:42 CET |
GENTIAN DIAGNOSTICS ASA | Share capital increase registered - Correction* | 20103010 Biotechnology | Total number of voting rights and capital |
| 09 Dec 2021 15:02 CET |
GENTIAN DIAGNOSTICS ASA | Share capital increase registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 30 Nov 2021 15:06 CET |
GENTIAN DIAGNOSTICS ASA | Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 29 Nov 2021 16:22 CET |
GENTIAN DIAGNOSTICS ASA | Share Issue in Connection with Employee Share Purchase Program | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2021 12:31 CET |
GENTIAN DIAGNOSTICS ASA | Multicenter study confirms calprotectin’s role in risk stratification in COVID-19 | 20103010 Biotechnology | Non-regulatory press releases |
| 01 Nov 2021 13:07 CET |
GENTIAN DIAGNOSTICS ASA | New study supports the value of calprotectin in management of COVID-19 patients | 20103010 Biotechnology | Non-regulatory press releases |
| 21 Oct 2021 08:00 CEST |
GENTIAN DIAGNOSTICS ASA | Third quarter 2021 financial report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 11 Oct 2021 15:23 CEST |
GENTIAN DIAGNOSTICS ASA | Flaggemelding | 20103010 Biotechnology | Flagging |
| 05 Oct 2021 18:00 CEST |
GENTIAN DIAGNOSTICS ASA | Product and market developments update | 20103010 Biotechnology | Inside information |
| 05 Oct 2021 15:12 CEST |
GENTIAN DIAGNOSTICS ASA | Invitation to presentation of third quarter results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Sep 2021 15:48 CEST |
GENTIAN DIAGNOSTICS ASA | Norron Sicav Flagging i Gentian Diagnostics ASA | 20103010 Biotechnology | Flagging |
| 26 Aug 2021 08:16 CEST |
GENTIAN DIAGNOSTICS ASA | Flaggemelding, Salix AS - Gentian Diagnostics ASA | 20103010 Biotechnology | Flagging |
| 25 Aug 2021 18:38 CEST |
GENTIAN DIAGNOSTICS ASA | Mandatory notification of trade and disclosure of large shareholding | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 25 Aug 2021 08:00 CEST |
GENTIAN DIAGNOSTICS ASA | Second quarter 2021 report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 19 Aug 2021 13:00 CEST |
GENTIAN DIAGNOSTICS ASA | Invitation to presentation of second quarter results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Jun 2021 11:48 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics ASA – Approval and publication of prospectus, and transfer of listing from Euronext Growth (Oslo) to Oslo Børs | 20103010 Biotechnology | Prospectus / admission document |
| 23 Jun 2021 11:48 CEST |
GENTIAN DIAGNOSTICS ASA | Transfer of shares to Oslo Børs approved, prepared for accelerated growth | 20103010 Biotechnology | Non-regulatory press releases |
| 23 Jun 2021 10:53 CEST |
GENTIAN DIAGNOSTICS ASA | Oslo Børs - Vedtatt overføring av notering fra Euronext Growth til Oslo Børs – Gentian Diagnostics ASA | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 23 Jun 2021 10:53 CEST |
GENTIAN DIAGNOSTICS ASA | Oslo Børs – Resolution of transfer of listing from Euronext Growth to Oslo Børs – Gentian Diagnostics ASA | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Jun 2021 07:30 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: Invitation to virtual presentation at 24 June | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Jun 2021 07:15 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: A long-term revenue ambition of NOK 1 billion from a portfolio of high-impact diagnostic tests | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |